{"id":"W4415209006","doi":"10.1038/s41591-025-03993-0","title":"Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Tolerability; Placebo; Adverse effect; Regimen; Demographics; Human immunodeficiency virus (HIV); Clinical endpoint; Viral load; Phases of clinical research; Monoclonal","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003795089,0.001832706,0.003332308,0.0006183541,0.0007832253,0.001236236,0.001012651,0.002497646,0.006952879],"category_scores_gemma":[0.002546587,0.0008891887,0.001748013,0.0005307331,0.001285748,0.001306449,0.0004243766,0.002741441,0.001051758],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005508378,"about_ca_system_score_gemma":0.001311862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005530527,"about_ca_topic_score_gemma":0.001089802,"domain_scores_codex":[0.9985849,0.0007991805,0.00009427372,0.0002399786,0.0001250429,0.000156682],"domain_scores_gemma":[0.9987909,0.0003525475,0.0002565406,0.0001028647,0.0001331494,0.0003639754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9660904,0.01491527,0.000437105,0.0009208375,0.000620021,0.00004173641,0.0000522736,0.0001528884,0.003763524,0.00009725046,0.0008096959,0.01209892],"study_design_scores_gemma":[0.9357623,0.06202563,0.0008883299,0.00002868829,0.0002346143,0.00002091996,0.00001270039,0.0001501657,0.0002659652,0.00006117011,0.0005410045,0.000008450138],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9494039,0.008781759,0.002420073,0.00131594,0.001099016,0.03137456,0.002943123,0.0002779499,0.00238363],"genre_scores_gemma":[0.952235,0.00535639,0.005259944,0.002079046,0.0009909412,0.02909089,0.00150119,0.00005693933,0.003429592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006952879,"threshold_uncertainty_score":0.0232597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006421785701943431,"score_gpt":0.3129191292011521,"score_spread":0.3064973434992087,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}